Androgens, health and sexuality in women and men

Maturitas

Volumn 67, Issue 3, 2010, Pages 275-289

  Wylie, Kevan ^a,b   Rees, Margaret ^a,b   Hackett, Geoff ^a,b   Anderson, Richard ^a,b   Bouloux, Pierre Marc ^a,b   Cust, Mike ^a,b   Goldmeier, David ^a,b   Kell, Philip ^a,b   Terry, Tim ^a,b   Trinick, Tom ^a,b   Wu, Frederick ^a,b  

^a Porterbrook Clinic   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Androgens; Female sexual dysfunction; Hypogonadism; Libido; Male sexual dysfunction; Sexuality; Testosterone

Indexed keywords

ANDROGEN; ESTRADIOL; NORETHISTERONE ACETATE; TESTOSTERONE; TIBOLONE;

ANDROGEN DEFICIENCY; CONSULTATION; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY; UNITED KINGDOM;

ANDROGENS; CLINICAL TRIALS AS TOPIC; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; LIBIDO; MALE; MEN'S HEALTH; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; WOMEN'S HEALTH;

EID: 77958106876     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.07.011     Document Type: Review

References (154)

1. G. Bachmann, J. Bancroft, and G. Braunstein Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment Fertil Steril 77 2002 660 665
2. R. Basson Women's sexual function and dysfunction: current uncertainties, future directions Int J Impot Res 20 5 2008 466 478
3. S. Davison, R. Bell, and S. Donath Androgen levels in adult females: changes with age, menopause and oophorectomy J Clin Endocrinol Metab 90 2005 3847 3853
4. J.B. Spencer, M. Klein, A. Kumar, and R. Azziz The age-associated decline of androgens in reproductive age and menopausal Black and White women J Clin Endocrinol Metab 92 December (12) 2007 4730 4733
5. W. Rosner, R.J. Auchus, R. Azziz, P.M. Sluss, and H. Raff Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement J Clin Endocrinol Metab 92 February (2) 2007 405 413
6. R. Basson, J. Berman, and A. Burnett Report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications J Urol 163 2000 888 893
7. S. Mimoun, and K. Wylie Female sexual dysfunctions: definitions and classification Maturitas 63 2 2009 116 118
8. K. Wylie, and M. Silvain Sexual response models in women Maturitas 63 2009 112 115
9. E.O. Laumann, A. Paik, and R.C. Rosen Sexual dysfunction in the United States: prevalence and predictors JAMA 281 1998 537 544
10. S.T. Lindau, L.P. Schumm, E.O. Laumann, W. Levinson, C.A. O'Muircheartaigh, and L.J. Waite A study of sexuality and health among older adults in the United States N Engl J Med 357 8 2007 August 23 762 774
11. E.D. Moreira, D.B. Glasser, A. Nicolosi, F.G. Duarte, C. Gingell GSSAB Investigators' Group Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe BJU Int 101 April (8) 2008 1005 1011
12. J.L. Shifren, B.U. Monz, P.A. Russo, A. Segreti, and C.B. Johannes Sexual problems and distress in United States women: prevalence and correlates Obstet Gynecol 112 November (5) 2008 970 978
13. A. Paik, and E.O. Laumann Prevalence of women's sexual problems in the USA I. Goldstein, C. Meston, S.R. Davis, A.M. Traish, Women's sexual function and dysfunction: study, diagnosis and treatment 2006 Taylor & Francis London
14. A. Graziottin, P.E. Koochaki, C. Rodenberg, and L. Dennerstein The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries J Sex Med 6 8 2009 2143 2153
15. S.R. Leiblum, P.E. Koochaki, and C.A. Rodenberg Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS) Menopause 13 2006 46 56
16. S. Bhasin, P. Enzlin, A. Coviello, and R. Basson Sexual dysfunction in men and women with endocrine disorders Lancet 369 9561 2007 February 17 597 611
17. A. Veronelli, C. Mauri, and B. Zecchini Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report J Sex Med 6 June (6) 2009 1561 1568
18. J. Pitkin, M. Rees British Menopause Society Council Urogenital atrophy Menopause Int 14 September (3) 2008 136 137
19. A. Aziz, M. Brannstrom, C. Bergquist, and G. Silfverstolpe Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being Fertil Steril 83 2005 1021 1028
20. C.M. Farqhuar, S.A. Harvey, Y. Yu, L. Sadler, and E.W. Stewart A prospective study of three years of outcomes after hysterectomy with and without oophorectomy Obstet Gynecol 194 2006 714 717
21. V. Teplin, E. Vittinghoff, F. Lin, L.A. Learman, and H.E. Richter Kuppermann oophorectomy in premenopausal women: health-related quality of life and sexual functioning Obstet Gynecol 109 2007 347 354
22. J.L. Shifren, and N.E. Avis Surgical menopause: effects on psychological well-being and sexuality Menopause 14 3 Pt 2 2007 May-June 586 591
23. A. Guay, J. Jacobson, and R. Munarriz Serum androgen levels in healthy premenopausal women with and without sexual dysfunction. Part B. Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction Int J Impot Res 16 April (2) 2004 121 129 (Pubitemid 38579456)
24. S.R. Davis, S.L. Davison, S. Donath, and R.J. Bell Circulating androgen levels and self-reported sexual function in women JAMA 294 2005 91 96 (Pubitemid 41002843)
25. N. Santoro, J. Torrens, and S. Crawford Correlates of circulating androgens in mid-life women: the Study of Women's Health Across the Nation (SWAN) J Clin Endocrinol Metab 90 2005 4836 4845
26. J.G. van der Stege, H. Groen, and S.J. van Zadelhoff Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure Menopause 15 1 2008 January-February 23 31
27. L. Dennerstein, R. Hayes, M. Sand, and P. Lehert Attitudes toward and frequency of partner interactions among women reporting decreased sexual desire J Sex Med 6 June (6) 2009 1668 1673
28. S.R. Leiblum, P.E. Koochaki, C.A. Rodenberg, I.P. Barton, and R.C. Rosen Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS) Menopause 13 2006 46 56
29. R.D. Hayes, L. Dennerstein, C.M. Bennett, P.E. Koochaki, S.R. Leiblum, and A. Graziottin Relationship between hypoactive sexual desire disorder and aging Fertil Steril 87 2007 107 112
30. V. Harsh, E.L. McGarvey, and A.H. Clayton Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study J Sex Med 5 March (3) 2008 640 645
31. G. Brock, A. Nicolosi, D.B. Glasser, C. Gingell, and J. Buvat Sexual problems reported by men and women in 28 countries: results of the Global Study of Sexual Attitudes and Behaviours Int J Impot Res 14 2002 S57 S58
32. A. Graziottin Prevalence and evaluation of sexual health problems - HSDD in Europe J Sex Med 4 Suppl. 3 2007 211 219
33. A.H. Clayton, E.R. Goldfischer, and I. Goldstein Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD) J Sex Med 6 3 2009 730 738
34. E.R. Goldfischer, A.H. Clayton, I. Goldstein, D. Lewis-D'Agostino, and R. Pyke Decreased Sexual Desire Screener (DSDS) for diagnosis of hypoactive sexual desire disorder in women Obstet Gynecol 111 2008 109S
35. N.A. Mazer, S.R. Leiblum, and R.C. Rosen The Brief Index of Sexual Functioning for Women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations Menopause 7 September-October (5) 2000 350 363
36. L. Derogatis, J. Rust, and S. Golombok Validation of the Profile of Female Sexual Function (PFSF) in surgically and naturally menopausal women J Sex Marital Ther 30 January-February (1) 2004 25 36
37. R. Rosen, C. Brown, and S. Leiblum Female Sexual Function Index J Sex Marital Ther 26 2000 191 208
38. S. Kingsberg Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women J Sex Med 4 Suppl. 3 2007 227 234
39. A.H. Clayton Sexual function and dysfunction in women Psychiatr Clin North Am 26 2003 673 678
40. R.J. Santen, D.C. Allred, and S.P. Ardoin Postmenopausal hormone therapy: an Endocrine Society Scientific Statement J Clin Endocrinol Metab Suppl. 1 2010 S1 S66
41. R. Basson, L.A. Brotto, E. Laan, G. Redmond, and W.H. Utian Assessment and management of women's sexual dysfunctions: problematic desire and arousal J Sex Med 2 May (3) 2005 291 300
42. K.R. Wylie, and R. Hallam-Jones Inhibited arousal in women J Fam Psychother 20 2009 150 176
43. K.R. Wylie, and F. Malik A review of drug treatment for female sexual dysfunction Int J STD AIDS 20 2009 671 674
44. M.E. Wierman, R.E. Nappi, and N. Avis Endocrine aspects of women's sexual function J Sex Med 7 2010 561 585
45. J.M. Krapf, and J.A. Simon The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women Maturitas 63 3 2009 213 219
46. M.E. Wierman, R. Basson, and S.R. Davis Androgen therapy in women: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 91 October (10) 2006 3697 3710
47. L. Dennerstein, J. Randolph, J. Taffe, E. Dudley, and H. Burger Hormones, mood, sexuality and the menopause transition Fertil Steril 77 Suppl. 4 2002 S42 48
48. Somboonporn W, Bell RJ, Davis SR. Testosterone for peri and postmenopausal women. Cochrane Database Syst Rev; 2005 (4). Art. No.: CD004509. DOI: 10.1002/14651858.CD004509.pub2.
49. E. Barrett-Connor, R. Young, and M. Notelovitz A two year double blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles J Reprod Med 44 1999 1012 1020
50. A.S. Dobs, T. Nguyen, C. Pace, and C.P. Roberts Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in post menopausal women J Clin Endocrinol Metab 87 2002 1509 1516
51. A. Floter, J. Nathorst-Boos, K. Carlstrom, and B. von Schoultz Addition of testosterone to estrogen replacement therapy in oophorectomised women: effects on sexuality and wellbeing Climacteric 5 2002 357 365
52. R.A. Lobo, R.C. Rosen, H.M. Yang, B. Block, and R.G. Van Der Hoop Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in post menopausal women with hypoactive sexual desire Fertil Steril 79 2003 1341 1352
53. P. Sarrel, B. Dobay, and B. Wilta Estrogen and estrogen androgen replacement in postmenopausal women dissatisfied with estrogen only therapy. Sexual behaviour and neuroendocrine responses J Reprod Med 43 1998 847 856
54. J.K. Warnock, S.G. Swanson, R.W. Borel, L.M. Zipfel, and J.J. Brennan Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women Menopause 12 4 2005 374 384
55. F. Labrie, V. Luu-The, and A. Belanger Is dihydroepiandrosterone a hormone? J Endocrinol 187 2005 169 196
56. F. Labrie, A. Belanger, C. Labrie, B. Candas, L. Cusan, and J.L. Gomez Bioavailability and metabolism of oral and percutaneous dihydroepiandrosterone in postmenopausal women J Steroid Biochem Mol Biol 107 2007 57 69 (Pubitemid 47362670)
57. M. Panjari, and S.R. Davis DHEA therapy for women: effect on sexual function and wellbeing Hum Reprod Update 13 2007 239 248
58. M. Panjari, and S.R. Davis DHEA for postmenopausal women: a review of the evidence Maturitas 66 2 2010 172 179
59. J. Parasrampuria, K. Schwarz, and R. Petesch Quality control of dihydroepiandrosterone dietary supplement products JAMA 280 1998 1565
60. E.A. Nijland, W.C. Weijmar Schultz, and J. Nathorst-Boös Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial J Sex Med 5 3 2008 646 656
61. S.R. Davis The effects of tibolone on mood and libido Menopause 9 3 2002 162 170
62. G.H. Burger, J. Hailes, M. Menelaus, J. Nelson, B. Hudson, and N. Balazs The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical lipid and hormonal results Maturitas 6 1984 351 358
63. H. Burger, J. Hailes, J. Nelson, and M. Menelaus Effect of combined impants of oestradiol and testosterone on libido in postmenopausal women BMJ 294 1987 936 937 (Pubitemid 17051529)
64. S.R. Davis, P. McCloud, B.J. Strauss, and H. Burger Testosterone enhances oestradiol's effects on postmenopausal bone density and sexuality Maturitas 21 1995 227 236
65. M.G. Dow, D.M. Hart, and C.A. Forrest Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study Brit J Obstet Gynaecol 90 1983 361 366
66. B.B. Sherwin, M.M. Gelfand, and W. Brender Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in the surgical menopause Psychosom Med 47 1985 339 351
67. J.L. Shifren, G.D. Braunstein, and J.A. Simon Transdermal testosterone treatment in women with impaired sexual function after oophorectomy N Engl J Med 343 2000 682 688
68. G.D. Braunstein, D.A. Sundwall, and M. Katz Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women Arch Intern Med 165 2005 1582 1589
69. J.E. Buster, S.A. Kingsberg, and O. Aguirre Testosterone patch for low sexual desire in surgically menopausal women: a randomised trial Obstet Gynecol 105 2005 944 952
70. J. Simon, G. Braunstein, and L. Nachtigall Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder J Clin Endocrinol Metab 90 2005 5226 5233
71. S. Kingsberg, J. Shifren, K. Wekselman, C. Rodenberg, P. Koochaki, and L. Derogatis Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in post menopausal women with hypoactive sexual desire disorder J Sex Med 4 2007 1001 1008
72. S.R. Davis, M. Moreau, and R. Kroll Testosterone for low libido in post menopausal women not taking estrogen New Engl J Med 359 2008 2005 2017
73. J. Nathorst Boos, A. Floter, M. Jarkander Rolff, K. Carlstrom, and B. Schoultz Treatment with per cutaneous testosterone gel in post menopausal women with decreased libido-effects on sexuality and psychological well-being Maturitas 53 2006 11 18
74. B. Chudakov, I.Z. Ben Zion, and R.H. Belmaker Trandermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the Arizona Sexual Experiences Scale for Females and Sexual Function Questionnaire J Sex Med 4 2007 204 208
75. G.D. Braunstein Safety of testosterone treatment in postmenopausal women Fertil Steril 88 2007 1 17
76. C.L. Shufelt, and G.D. Braunstein Safety of testosterone use in women Maturitas 63 1 2009 May 20 63 66
77. C.L. Shufelt, and G.D. Braunstein Testosterone and the breast Menopause Int 14 September (3) 2008 117 122
78. M.M. Gelfand, and B. Witta Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941-1996 Clin Ther 19 1997 383 404
79. R.M. Tamimi, S.E. Hankinson, W.Y. Chen, B. Rosner, and G.A. Colditz Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women Arch Intern Med 166 2006 1483 1489
80. R.B. Ness, J.D. Albano, A. McTiernan, and J.A. Cauley Influence of estrogen plus testosterone supplementation on breast cancer Arch Intern Med 169 1 2009 41 46
81. T.P. Van Staa, and J.M. Sprafka Study of adverse outcomes in women using testosterone therapy Maturitas 62 1 2009 76 80
82. M. Panjari, R.J. Bell, F. Jane, J. Adams, C. Morrow, and S.R. Davis The safety of 52 weeks of oral DHEA therapy for postmenopausal women Maturitas 63 3 2009 240 245
83. R. Basson Female sexual response: the role of drugs in the management of sexual dysfunction Obstet Gynecol 98 2001 350 353
84. L.R. Schover Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk? Fertil Steril 90 2008 129 140
85. North American Menopause Society The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society Menopause 12 5 2005 September-October 496 511
86. North American Menopause Society Estrogen and progesterone use in post menopausal women: 2010 position statement of the North American Menopause Society Menopause 17 2010 242 255
87. M.H. Thom, W.P. Collins, and J.W. Studd Hormonal profiles in postmenopausal women after therapy with subcutaneous implants Br J Obstet Gynaecol 88 4 1981 426 433
88. J.S. Brand, and Y.T. Van Der Schouw Testosterone, SHBG and cardiovascular health in post-menopausal women Int J Impot Res 22 2010 91 104
89. E.M. Gurnell, P.J. Hunt, and S.E. Curran Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial J Clin Endocrinol Metab 93 February (2) 2008 400 409
90. D. Barad, H. Brill, and N. Gleicher Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function J Assist Reprod Genet 24 December (12) 2007 629 634
91. S. Weil, K. Vendola, J. Zhou, and C.A. Bondy Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development J Clin Endocrinol Metab 84 August (8) 1999 2951 2956
92. K.A. Walters, C.M. Allan, and D.J. Handelsman Androgen actions and the ovary Biol Reprod 78 March (3) 2008 380 389
93. M. Goto, K. Piper Hanley, and J. Marcos In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development J Clin Invest 116 2006 953 960
94. C. Wang, E. Nieschlag, and R.S. Swerdloff ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males Aging Male 12 1 2009 5 12
95. S. Bhasin, G.R. Cunningham, and F.J. Hayes Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 6 2010 2536 2559
96. J. Buvat, M. Maggi, and L. Gooren Endocrine aspects of male sexual dysfunctions J Sex Med 7 4 Pt 2 2010 1627 1656
97. M. Dabbs, and J.M. Dabbs Heroes, rogues, and lovers: testosterone and behavior 2000 McGraw-Hill New York
98. A. Morales, C.C. Schulman, J. Tostain, and C.W. Wu Testosterone deficiency syndrome (TDS) needs to be named appropriately - the importance of accurate terminology Eur Urol 50 2006 407 409
99. F.C. Wu, A. Tajar, and J.M. Beynon Identification of late-onset hypogonadism in middle-aged and elderly men N Engl J Med 2010 Jun 16 [Epub ahead of print]
100. C. Wang, D.H. Catlin, L.M. Demers, B. Starcevic, and R.S. Swerdloff Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry J Clin Endocrinol Metab 89 2004 534 543
101. R.S. Swerdloff, and C. Wang Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence Clin Chem 54 2008 458 460
102. N.A. Mazer A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations Steroids 74 6 2009 512 519
103. C. Wang, S. Plymate, E. Nieschlag, and C.A. Paulsen Salivary testosterone in men: further evidence of a direct correlation with free serum testosterone J Clin Endocrinol Metab 53 1981 1021 1024
104. J.T. Citron, B. Ettinger, and H. Rubinoff Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism J Urol 155 1996 529 533
105. T.J. Bunch, D. Abraham, S. Wang, and A.W. Meikle Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction Aging Male 5 2002 38 46
106. E.L. Rhoden, C. Estrada, L. Levine, and A. Morgentaler The value of pituitary magnetic resonance imaging in men with hypogonadism J Urol 170 2003 795 798
107. J. Buvat, and A. Lemaire Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy J Urol 158 1997 1764 1767
108. S. Bhasin, G.R. Cunningham, and F.J. Hayes Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 91 2006 1995 2010
109. A.B. Araujo, A. O'Donnell, and D.J. Brambilla Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study J Clin Endocrinol Metab 89 2004 5920 5926
110. A. Vermeulen Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays J Endocrinol Invest 28 2005 28 31
111. W. Rosner, R.J. Auchus, R. Azziz, P.M. Sluss, and H. Raff Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement J Clin Endocrinol Metab 92 2007 405 413
112. C. Wang, D.H. Catlin, L.M. Demers, B. Starcevic, and R.S. Swerdloff Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry J Clin Endocrinol Metab 89 2004 534 543
113. C.H. Mercer, K.A. Fenton, and A.M. Johnson Sexual function problems and help seeking behaviour in Britain: national probability sample survey BMJ 327 2003 426 427
114. A.B. Araujo, G.R. Esche, and V. Kupelian Prevalence of symptomatic androgen deficiency in men J Clin End Metab 92 2007 4241 4247
115. K.R. Wylie, and D. Davies-South A study of treatment choices in men with erectile dysfunction and reduced androgen levels J Sex Marital Ther 30 2 2004 107 114
116. J. Buvat, and G. Bou Jaoudé Significance of hypogonadism in erectile dysfunction World J Urol 24 6 2006 657 667
117. J. Buvat, and A. Lemaire Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy J Urol 158 5 1997 1764 1767
118. D. Kapoor, H. Aldred, S. Clark, K.S. Channer, and T.H. Jones Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity Diabetes Care 30 2007 911 917
119. D. Kapoor, K. Channer, H. Aldred, T. Hugh Jones, and S. Clark Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes Diabetes Care 30 4 April 2007
120. G. Hackett, P. Kell, and D. Ralph British Society for Sexual Medicine guidelines on the management of erectile dysfunction J Sex Med 5 2008 1841 1865
121. A. Shabsigh, Y. Kang, and R. Shabsign Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism J Sex Med 2 2005 716 721
122. R. Shabsigh, J.M. Kaufman, C. Steidle, and H. Padma-Nathan Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone J Urol 172 2004 658 663
123. E.A. Greco, G. Spera, and A. Aversa Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidence Eur Urol 50 2006 940 947
124. E. Nieschlag, R. Swerdloff, and H.M. Behre Investigation, treatment and monitoring of late-onset hypogonadism in males Aging Male 8 2005 56 58
125. E. Nieschlag, R. Swerdloff, and H.M. Behre Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations Int J Androl 28 2005 125 127 (Pubitemid 40780337)
126. E. Nieschlag, R. Swerdloff, and H.M. Behre Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations J Androl 27 2006 135 137
127. E. Nieschlag, R. Swerdloff, and HM Behre Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations Eur Urol 48 2005 1 4 (Pubitemid 40835584)
128. A.M. Black, A.G. Day, and A. Morales The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJU Int 94 2004 1066 1070
129. M. Zitzmann, and E. Nieschlag Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men J Clin Endocrinol Metab 92 2007 3844 3853
130. O.M. Calof, A.B. Singh, and M.L. Lee Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J Gerontol A Biol Sci Med Sci 60 2005 1451 1457
131. J.K. Parsons, H.B. Carter, E.A. Platz, E.J. Wright, P. Landis, and E.J. Metter Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy Cancer Epidemiol Biomarkers Prev 14 2005 2257 2260
132. P.J. Drinka, A.L. Jochen, M. Cuisinier, R. Bloom, I. Rudman, and D. Rudman Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels J Am Geriatr Soc 43 1995 899 901
133. A.W. Roddam, N.E. Allen, P. Appleby, and T.J. Key Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies J Natl Cancer Inst 100 2008 170 183
134. W.R. Carpenter, W.R. Robinson, and P.A. Godley Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer J Natl Cancer Inst 100 2008 158 159
135. R. Shabsigh, E.D. Crawford, A. Nehra, and K.M. Slawin Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review Int J Impot Res 21 2008 9 23
136. L.J. Gooren Androgens and male aging: current evidence of safety and efficacy Asian J Androl 12 2 2010 136 151
137. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534 (Pubitemid 43898816)
138. I.M. Thompson, P.R. Carroll, and M.A. Carducci Recommendations for defining and treating high risk localized prostate cancer J Urol 176 2006 S6 S10
139. P.K. Agarwal, and M.G. Oefelein Testosterone replacement therapy after primary treatment for prostate cancer J Urol 173 2005 533 536
140. M. Khera, and L.I. Lipshultz The role of testosterone replacement therapy following radical prostatectomy Urol Clin North Am 34 2007 549 553 vi
141. M.F. Sarosdy Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy Cancer 109 2007 536 541
142. E. Nieschlag Testosterone treatment comes of age: new options for hypogonadal men Clin Endocrinol (Oxf) 65 2006 275 281
143. World Health Organization WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction 4th ed. 1999 Cambridge University Press Cambridge
144. D. Büchter, H.M. Behre, S. Kliesch, and E. Nieschlag Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases Eur J Endocrinol 139 September (3) 1998 298 303
145. P.Y. Liu, H.W. Baker, V. Jayadev, M. Zacharin, A.J. Conway, and D.J. Handelsman Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome J Clin Endocrinol Metab 94 March (3) 2009 801 808
146. A.S. Burris, R.V. Clark, D.J. Vantman, and R.J. Sherins A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy Fertil Steril 50 August (2) 1988 343 347
147. R.R. Kalyani, and A.S. Dobs Androgen deficiency, diabetes, and the metabolic syndrome in men Curr Opin Endocrinol Diabetes Obes 14 2007 226 234
148. C.A. Derby, S. Zilber, D. Brambilla, K.H. Morales, and J.B. McKinlay Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study Clin Endocrinol 65 2006 125 131
149. V. Kupelian, S.T. Page, A.B. Araujo, T.G. Travison, W.J. Bremner, and J.B. McKinlay Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men J Clin Endocrinol Metab 91 2006 843 850
150. C.A. Allan, B.J. Strauss, and R.I. McLachlan Body composition, metabolic syndrome and testosterone in ageing men Int J Impot Res 19 5 2007 448 457
151. C.A. Allan, B.J. Strauss, H.G. Burger, E.A. Forbes, and R.I. McLachlan Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non obese aging men J Clin Endocrinol Metab 93 2008 139 146
152. A.M. Kenny, K.M. Prestwood, and L.G. Raisz Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels Endocr Res 26 2000 153 168
153. S.S. Freitas, E. Barrett-Connor, and K.E. Ensrud Rate and circumstances of clinical vertebral fractures in older men Osteoporos Int 19 2007 615 623
154. J.T. Schousboe, B.C. Taylor, and H.A. Fink Cost effectiveness of bone densitometry followed by treatment of osteoporosis in older men JAMA 298 2007 629 637